Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

3,256 evidence items · page 87 / 131

45.9 %The overall average prevalence of P. falciparum infection in Dienga was 45.9% (95%CI [37.0–54.7]).

Gabonpaludismepublished 2016PloS oneeurope_pmcdocument of 9 observations

18 %The rate of methicillin-resistant Staphylococcus aureus (MRSA) colonization in humans from both hospital and community settings in Gabon was 18%.

Gabonmethicillin-resistant Staphylococcus aureus (MRSA)published 2025Diagnostic microbiology and infectious diseaseeurope_pmcdocument of 3 observations

3.1 %Between November 2018 and March 2023, 3 out of 98 sheep (3.1%) tested positive for NP and GP anti-EBOV antibodies.

GabonEBOVobserved November 2018 to March 2023published 2025PloS oneeurope_pmcdocument of 6 observations

Loa loa infection was associated with presence of eosinophilia and absolute eosinophil counts were associated with extent of microfilaremia.

Gaboneosinophilia · loase · microfilaremiapublished 2022PLoS neglected tropical diseasesOpenAlexdocument of 4 observationsDOI 10.1371/journal.pntd.0010793

2 trialsIn 2 of the 7 trials with sufficient data, protected males had significantly higher levels of antibodies to PfCSP than unprotected males.

Gabonpaludismepublished 2022Frontiers in immunologyPubMeddocument of 5 observations

IL-10 and IL-6 levels were higher in Plasmodium falciparum-infected asymptomatic children compared to uninfected children.

Gabonpaludismepublished 2021Clinical and experimental immunologyeurope_pmcdocument of 4 observationsDOI 10.1111/cei.13653

43 %Convulsions were observed in 43.0% of severe malaria cases.

Gabonpaludismeobserved 2019published 2023BMC Infectious DiseasesOpenAlexdocument of 14 observationsDOI 10.1186/s12879-023-08133-y

2.6 aORStunting was associated with low birth weight, with an adjusted odds ratio of 2.6 (95% confidence interval: 1.4–4.9) in infants from Lambaréné and Fougamou, Gabon.

Gabonfaible poids de naissance · malnutritionobserved 2009–2012published 2021PloS oneeurope_pmcdocument of 8 observationsDOI 10.1371/journal.pone.0246694

26 %The case fatality rate among hospitalised PLHIV with tuberculosis was 26.0% (n = 24).

Gabontuberculose · VIH/sidaobserved 2021-2022published 2025Southern African journal of infectious diseaseseurope_pmcdocument of 11 observationsDOI 10.4102/sajid.v40i1.695

64 %180 (64%) of the women with microscopic parasitaemia were teenagers.

Gabonpaludismepublished 2003Malaria JournalOpenAlexdocument of 5 observationsDOI 10.1186/1475-2875-2-18

3.4 %Plasmodium ovale was detected in 3.4% of afebrile children in Makokou, Gabon.

Gabonpaludismepublished 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 16 observations

1.21 odds_ratio_per_10_percent_FEV1_FVCHigher FEV1/FVC was associated with a higher risk of diabetes (OR per 10% = 1.21, 95% CI 1.08 to 1.35).

Gabondiabète (non précisé)published 2025BMJ open respiratory researcheurope_pmcdocument of 5 observations

18.69 %Salmonella was detected in 18.69% of food samples.

GabonSalmonellapublished 2021Journal of food science and technologyeurope_pmcdocument of 3 observations

7 mg/LThe level of C-reactive protein was 7 mg/L in pregnant women free of Plasmodium falciparum infection.

Gabonpaludismepublished 2006The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.2006.75.798

0.31 per_person_yearThe incidence of the first or only episode of clinical malaria in the intention-to-treat population was 0.31 per person-year in the RTS,S/AS01 group during the 14 months after the first dose.

Gabonpaludismepublished 2012The New England journal of medicineeurope_pmcdocument of 6 observations

34.7 %Visual impairment was bilateral in 34.7% of the 75 people living with HIV who had visual impairment.

GabonVIH/sida · visual impairmentpublished 2023Le Mali medicalPubMeddocument of 6 observations

94 %The polymerase chain reaction-corrected cure rate for quinine-clindamycin was 94% at day 28 of follow-up in the per-protocol population.

Gabonpaludismepublished 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 3 observationsDOI 10.1086/430309

6 patientsArtemether and its active metabolite dihydroartemisinin were undetectable in hair samples from six falciparum malaria patients.

Gabonpaludismepublished 2025New microbes and new infectionsPubMeddocument of 4 observations

69.2 %HPV 16 was found in 69.2% of adenocarcinoma cases among Gabonese women.

Gabonadenocarcinomaobserved 2007–2013 and August 2013published 2016Infectious agents and cancerPubMeddocument of 10 observations

60.4 %Malaria prevalence in febrile patients included in the study was 60.4% (122/202).

Gabonpaludismeobserved 2016published 2021Journal of global antimicrobial resistanceeurope_pmcdocument of 12 observations

7 out_of_12Pyronaridine treatment of mice infected with S. mansoni at the prepatent stage cured 7 out of 12 animals.

Gabonschistosomiasepublished 2021PLoS neglected tropical diseaseseurope_pmcdocument of 5 observationsDOI 10.1371/journal.pntd.0009511

34 %Mothers with AA status screen 34% of their children.

GabondrépanocytoseHAL · Unilimdocument of 90 observations

57.9 %57.9% of people living with HIV/AIDS had developed opportunistic infections.

Gabonopportunistic infections · VIH/sidapublished 2024Viruseseurope_pmcdocument of 5 observations

0.43 infectionsThe mean number of vector-borne infections was 0.43 (standard deviation 0.63) in HIV-positive pregnant women.

Gabonvector-borne infections · VIH/sidapublished 2023Infectious diseases of povertyPubMeddocument of 7 observations

1,226 patientsOf the 4,116 children treated, 1,226 were treated with artemether-lumefantrine.

Gabonpaludismepublished 2011PLoS medicineeurope_pmcdocument of 15 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.